M. J. Quinn, K. A. Crotty, J. F. Thompson, A. S. Coates, C. J. O'brien et al., Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients, Cancer, vol.83, pp.1128-1135, 1998.

A. H. Shain, M. Garrido, and T. Botton, Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway, Nat Genet, vol.47, pp.1194-1199, 2015.

C. Robert, J. Schachter, and G. V. Long, Pembrolizumab versus Ipilimumab in advanced melanoma, N Engl J Med, vol.372, pp.2521-2532, 2015.

Z. R. Chalmers, C. F. Connelly, and D. Fabrizio, Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden, Genome Med, vol.9, issue.1, p.34, 2017.

Z. Eroglu, J. M. Zaretsky, and S. Hu-lieskovan, High response rate to PD-1 blockade in desmoplastic melanomas, Nature, vol.553, issue.7688, pp.347-350, 2018.

,